Simplifying Global Compliance
FDA Sends Warning Letters to CIs for Deviating from Protocols
Clinical Trials Advisor
The FDA has issued warning letters to two clinical investigators who deviated from their investigational plans.
To View This Article:
Subscribe To Clinical Trials Advisor
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing